DOW — Q3 2026 Financial Report Analysis

Overview

Dow's third quarter of 2026 (three months ended September 30) was far better than a year ago but much weaker than the quarter just before it. Net sales rose 13% to $11.27 billion, almost entirely because Dow charged more: local price (the price change measured in each region's own currency, so exchange-rate moves are stripped out) was up 14%, currency was flat and volume fell 1%. Net income available to Dow Inc. common stockholders was $458 million, or $0.62 per diluted share, against $62 million ($0.08) a year earlier.

The year-over-year jump hides a sharp step down from Q2. Operating EBIT (Dow's main profit measure, explained below) was $887 million, up from $180 million a year ago but down 46% from $1,648 million in Q2 2026. Packaging & Specialty Plastics, the polyethylene business that drove Q2, earned $585 million against $1,278 million in Q2. This analysis is based on Dow's earnings release (8-K Exhibit 99.1, filed October 22, 2026). The full 10-Q, with management's discussion of results and the sequential bridge, had not been filed yet.

Key metrics

Dow's income statement has no "operating income" line. The company measures its businesses by Operating EBIT: pretax earnings before interest, excluding what it calls "significant items" such as restructuring charges and legal gains. Because it is a non-GAAP figure (not defined by standard accounting rules), the margin above is the Operating EBIT margin, not a GAAP operating margin. Total net income including the share owed to minority partners was $525 million; $67 million of that belongs to noncontrolling interests, mainly the outside investor that owns 49% of Dow's U.S. Gulf Coast infrastructure entity.

Where the sales growth came from

The last row matters. Hydrocarbons & Energy sells ethylene, propylene and other basic chemicals left over or traded from Dow's crackers (plants that break natural-gas liquids or naphtha into ethylene, the building block for polyethylene). Its sales rose because Dow restarted a previously idled cracker in EMEAI (Europe, Middle East, Africa and India). Excluding that business, Dow's volume fell 2%, not 1%. Packaging & Specialty Plastics' 1% volume gain owes part of its increase to the restarted cracker.

By region, prices rose everywhere: EMEAI +17%, U.S. & Canada +14%, Latin America +12%, Asia Pacific +9%. Volume rose in Latin America (+3%), the U.S. & Canada (+2%) and EMEAI (+2%) but fell 12% in Asia Pacific, so Asia Pacific was the only region where sales fell (-3%, to $1.78 billion).

Segment results (Operating EBIT)

Packaging & Specialty Plastics (polyethylene for packaging film, plus the Hydrocarbons & Energy business) made a 10.1% margin on sales, up from 4.1% a year ago but half of Q2's 20.0%. The release credits the year-over-year gain to "higher integrated margins as a result of higher polyethylene prices" and self-help savings, "partly offset by higher planned maintenance activity." It says polyethylene demand grew year over year "excluding supply constraints associated with the Middle East conflict." It does not explain the drop from Q2. Segment sales fell 9.5% from Q2's $6,385 million, which points to lower prices or mix versus Q2, but the 10-Q is needed to confirm that.

Industrial Intermediates & Infrastructure (polyurethanes, construction chemicals, industrial solvents) went from a $47 million loss to a $176 million profit on prices up 16%, despite volume down 7%. Part of the improvement is an accounting change rather than operations. Since Q1 2026, Dow no longer records its share of losses from Sadara, its 35%-owned Saudi joint venture, because the Sadara liabilities on its books have reached the full amount Dow is committed to cover. This segment's share of affiliate results went from -$68 million to +$11 million, a $79 million swing, and the release names the Sadara suspension as one driver. Against that, the release cites "higher energy costs in EMEAI." Industrial Solutions grew volume on "increased demand for AI infrastructure and energy applications," while Polyurethanes & Construction Chemicals lost volume to the Middle East conflict.

Performance Materials & Coatings (silicones, acrylics, architectural coatings) nearly doubled Operating EBIT to $154 million on 5% higher prices and 3% more volume. This is the segment where cost cutting shows most directly. The release credits self-help, "including the closure of the Barry, U.K. siloxanes plant." In Q2 that shutdown was a cost, and it is now a saving. Downstream silicones volume grew in all regions even as upstream volume fell after the closure.

What the headline numbers hide

• The year-ago GAAP figure was flattered by one-offs. Q3 2025's $0.08 GAAP EPS included $0.27 of one-off help: a $110 million gain on selling an affiliate stake and a $120 million tax benefit. Without them, Dow lost $0.19 per share that quarter. The swing in operating EPS (+$0.90, from -$0.19 to $0.71) is the cleaner measure of the improvement.
• This quarter's GAAP-to-operating gap is small and mixed. Significant items cost $0.09 per share in total, or $84 million pretax: $69 million of Transform to Outperform charges (Dow's 2026 restructuring and job-cut program), $31 million of implementation costs for the 2025 restructuring program, and a $53 million loss on paying off debt early. Partly offsetting those was a $69 million gain from Dow's legal matter with Nova Chemicals.
• No help from taxes or buybacks. The effective tax rate was 18.2% ($117 million on $642 million pretax), against a $54 million tax credit a year ago, so tax worked against the year-over-year comparison. Dow bought back no stock, and diluted shares rose 2.0% to 727.4 million, which slightly reduced EPS.
• Cash conversion was strong. Operating cash flow of $1,839 million was 3.5 times net income and 118% of Operating EBITDA. Management attributes the $515 million rise from Q2 mainly to working capital (cash tied up in receivables and inventory, minus what Dow owes suppliers). Dow's Q2 10-Q said a C$452 million (about US$318 million) tax refund tied to the Nova judgment was received on July 15, which falls in this quarter. The release does not say where that refund sits in the cash flow statement, so how much of Q3's operating cash it accounts for can't be confirmed until the 10-Q.
• Receivables have grown faster than sales this year. Trade receivables were $5,890 million at September 30, up 24% from $4,762 million at year-end, while nine-month sales rose 9%. Higher selling prices explain some of this. Payables rose by a similar amount ($5,300 million from $4,151 million), so overall working capital still released cash. The gap is worth watching if prices fall.
• Debt is coming down. Total borrowings (notes payable plus long-term debt, including the current portion) were $17,539 million, down about $620 million since December, in line with the CEO's "approximately $600 million" figure.

Did last time's read hold up?

Our Q2 report flagged three things for Q3. First, whether Packaging & Specialty Plastics could hold a margin near 20%: it did not. The margin fell to 10.1% and segment profit more than halved from Q2. That supports Q2's warning that its profit depended on unusually high polyethylene prices. Second, how quickly accrued severance would become cash payments: the earnings release does not break this out, so it has to wait for the 10-Q. Third, whether the Sadara debt guarantee would need another markup: Q3 carried no new Sadara charge among its significant items.

Takeaway: Q3 shows how much of Q2's profit came from polyethylene prices. Sales were still 13% higher than a year ago on price, yet Operating EBIT fell 46% from Q2 as the plastics margin roughly halved. What held up better is the part Dow controls. Cost cuts lifted the silicones and coatings segment, and the company generated $1.13 billion of free cash flow while paying down about $600 million of debt this year.

Year to date

For the nine months, net sales were $33,153 million (+9%), with local price +9%, currency +1% and volume -1%. Net income available to common stockholders was $646 million ($0.88 per share), against a $1,080 million loss. Operating EBIT was $2,689 million against $389 million, and operating EPS was $2.02 against -$0.58. Free cash flow was $2,446 million, against -$1,147 million a year earlier. Dividends paid fell to $758 million from $1,239 million after the dividend was halved in 2025.

Outlook

The release gives no numeric guidance for the fourth quarter. Management says Transform to Outperform is "on track to achieve the upsized $700 million in growth and productivity benefits in 2026" and about $2 billion of total uplift by the end of 2027. It also says its combined self-help actions will deliver "more than $1 billion of EBITDA uplift in both 2026 and 2027." In July, management talked of more than $1.3 billion of total in-year self-help benefits for 2026. The release does not say whether the two figures measure the same thing, so this is a change in wording, not a confirmed cut. Carter also says benefits from the first of three European plant shutdowns "are expected to build through 2027."

Our view: the self-help savings now look like the steadier source of earnings, and the price-driven part is shrinking. Polyethylene prices are still well above last year's, but profit from them fell sharply in one quarter. Asia Pacific volume is still falling and EMEAI energy costs are rising. For Q4, watch three things. First, whether the Packaging & Specialty Plastics margin settles near Q3's 10% or keeps falling toward last year's 4%. Second, whether working capital that came back as cash in Q3 gets absorbed again. Third, the 10-Q's explanation of the drop from Q2: how much came from price, from feedstock and energy costs, and from maintenance.